Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06257576 · ClinicalTrials.gov registry record · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
A Phase 3 study of Postoperative Urinary Tract Infection, sponsored by Emory University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 212
- Enrollment target
- 3
- Study locations
NCT06257576: Recruiting Phase 3 study of Postoperative Urinary Tract Infection, sponsored by Emory University.
NCT06257576 is a Phase 3 study of Postoperative Urinary Tract Infection that is actively recruiting participants, run by Emory University. The registered enrollment target is 212 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06257576, a Phase 3 study of Postoperative Urinary Tract Infection, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 212 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is being done to answer the question: What is the impact of a medication called tamsulosin (also called Flomax) on the rate of postoperative urinary retention (POUR) and catheter-associated urinary tract infection (UTI)? One of the most common complications following surgery and associated with Foley catheters is post-operative urinary retention (POUR) after the catheter is removed. This is defined as being unable to urinate spontaneously within 8 hours following the removal of the indwelling Foley catheter (the catheter that sits in your bladder to drain urine after surgery). When this happens, it requires intermittent straight catheterization of the bladder (placing a temporary catheter in the bladder to drain the buildup of urine), which can cause a lot of discomfort and anxiety, as well as increase the risk of catheter-associated urinary tract infection (CAUTI).
Primary Outcome
Researchers will document the incidence of postoperative urinary retention (POUR) rate, as defined as the inability to void within 8 hours after Foley catheter removal at midnight on postoperative day 1.
Conditions Studied
Interventions
- OTHER Control Group
- DRUG Tamsulosin
Study Locations (3)
Georgia
- Emory Saint Joseph's Hospital - Atlanta
- Emory University Hospital Midtown - Atlanta
- Emory University Hospital (EUH) - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2026-02 |
| Phase | Phase 3 |
What NCT06257576 shows while recruiting
NCT06257576 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Postoperative Urinary Tract Infection appearing as the primary indexed condition, and to 2 interventions - of which Control Group is the first listed.
NCT06257576 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06257576 about?
NCT06257576 is a clinical study titled "Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter". This study is being done to answer the question: What is the impact of a medication called tamsulosin (also called Flomax) on the rate of postoperative urinary retention (POUR) and catheter-associated urinary tract infection (UTI)? One of the most common complications following surgery and associate...
What is the current status of trial NCT06257576?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 212 participants. The study started on 2024-02-26. Estimated completion is 2026-02.
What conditions does trial NCT06257576 study?
This clinical trial studies the following conditions: Postoperative Urinary Tract Infection.
What interventions are being tested in trial NCT06257576?
The interventions under investigation include: Control Group (OTHER), Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT06257576?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06257576 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Urinary Tract Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06257576's enrollment target sits among peer trials
212 1336th of 2000 higher than 664 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06456593 · 212 participants · Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- NCT06515925 · 212 participants · NA
Our Whole Lives Gemini: Virtual Integrative Medical Group Visits for Managing Chronic Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI